[
  {
    "ts": "2026-01-12T01:31:34+00:00",
    "headline": "Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight",
    "summary": "On Thursday, Eli Lilly and Co. (NYSE:LLY) revealed topline results from the novel TOGETHER-PsA open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) compared to Taltz alone for active psoriatic arthritis (PsA) and obesity or overweight with at least one weight-related condition. Psoriatic arthritis is linked to psoriasis (a condition that affects skin and nails). It causes joint pain, stiffness, and a skin rash. At 36 weeks, treatment with conc",
    "url": "https://finance.yahoo.com/news/eli-lilly-study-finds-zepbound-013134669.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "decdd05a-2eb3-3f12-8f69-a129cf31f570",
      "content": {
        "id": "decdd05a-2eb3-3f12-8f69-a129cf31f570",
        "contentType": "STORY",
        "title": "Eli Lilly Study Finds Zepbound Dual Treatment Improves Arthritis, Helps Patients Lose Weight",
        "description": "",
        "summary": "On Thursday, Eli Lilly and Co. (NYSE:LLY) revealed topline results from the novel TOGETHER-PsA open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) compared to Taltz alone for active psoriatic arthritis (PsA) and obesity or overweight with at least one weight-related condition. Psoriatic arthritis is linked to psoriasis (a condition that affects skin and nails). It causes joint pain, stiffness, and a skin rash. At 36 weeks, treatment with conc",
        "pubDate": "2026-01-12T01:31:34Z",
        "displayTime": "2026-01-12T01:31:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Benzinga/ebc5670b38d99be85ea6a2f16ff0bb54",
          "originalWidth": 1000,
          "originalHeight": 666,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0iWz1yDq.CSuFi.9R45_Dw--~B/aD02NjY7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/ebc5670b38d99be85ea6a2f16ff0bb54.cf.webp",
              "width": 1000,
              "height": 666,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lSgReJnkqZecsqPPZ7zBjA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/ebc5670b38d99be85ea6a2f16ff0bb54.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "http://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-study-finds-zepbound-013134669.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-study-finds-zepbound-013134669.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T08:10:20+00:00",
    "headline": "ðŸŽ§ Markets Last Week: Defense Stocks Rose, Beer Beat, Pharma Deal",
    "summary": "How did American oil companies respond to the U.S. action in Venezuela? Why were Constellation investors happy with lower beer sales? Plus, can a big pharmaceutical deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana discusses the biggest stock moves last week and the news that drove them.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-12-2026/card/-markets-last-week-defense-stocks-rose-beer-beat-pharma-deal-70k35Bbxcihe7o36ppxS?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "73b15b5c-bbc4-3f07-899e-1e538d4e7eb5",
      "content": {
        "id": "73b15b5c-bbc4-3f07-899e-1e538d4e7eb5",
        "contentType": "STORY",
        "title": "ðŸŽ§ Markets Last Week: Defense Stocks Rose, Beer Beat, Pharma Deal",
        "description": "",
        "summary": "How did American oil companies respond to the U.S. action in Venezuela? Why were Constellation investors happy with lower beer sales? Plus, can a big pharmaceutical deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana discusses the biggest stock moves last week and the news that drove them.",
        "pubDate": "2026-01-12T08:10:20Z",
        "displayTime": "2026-01-12T08:10:20Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/73b15b5c-bbc4-3f07-899e-1e538d4e7eb5/%F0%9F%8E%A7-markets-last-week-defense.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-12-2026/card/-markets-last-week-defense-stocks-rose-beer-beat-pharma-deal-70k35Bbxcihe7o36ppxS?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T10:03:00+00:00",
    "headline": "Abivax Surges on Report Ely Lily is Preparing $17.5 Billion Bid",
    "summary": "Shares in Abivax surged on a report that  Eli Lilly  was ready to offer 15 billion euros ($17.45 billion) for the biotech startup.  Stock in the French company rose 22% in early European trading to 120.80 euros after climbing as much as 30% earlier in the session.  It has a market capitalization of around 7.78 billion euros.",
    "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
      "content": {
        "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
        "contentType": "STORY",
        "title": "Abivax Surges on Report Ely Lily is Preparing $17.5 Billion Bid",
        "description": "",
        "summary": "Shares in Abivax surged on a report that  Eli Lilly  was ready to offer 15 billion euros ($17.45 billion) for the biotech startup.  Stock in the French company rose 22% in early European trading to 120.80 euros after climbing as much as 30% earlier in the session.  It has a market capitalization of around 7.78 billion euros.",
        "pubDate": "2026-01-12T10:03:00Z",
        "displayTime": "2026-01-12T10:03:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/fe057970-c6c6-386f-9920-c8e2f0dc2d38/abivax-surges-on-report-ely.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/70b7d4c1389db409b9e1fc36a775438a",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sUf6G5CS045DS2VMIHzgWw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/70b7d4c1389db409b9e1fc36a775438a.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Z60wFKSaj18IKqHIUCGA_g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/70b7d4c1389db409b9e1fc36a775438a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T11:14:00+00:00",
    "headline": "Abivax shares surge after report flags continued Eli Lilly takeover interest",
    "summary": "Investing.com -- Shares in Abivax jumped sharply on Monday after a report said U.S. drugmaker Eli Lilly remains interested in acquiring the French biotech.",
    "url": "https://finance.yahoo.com/news/abivax-shares-surge-report-flags-111400639.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "dab409f1-460e-30af-9292-b8c81210803e",
      "content": {
        "id": "dab409f1-460e-30af-9292-b8c81210803e",
        "contentType": "STORY",
        "title": "Abivax shares surge after report flags continued Eli Lilly takeover interest",
        "description": "",
        "summary": "Investing.com -- Shares in Abivax jumped sharply on Monday after a report said U.S. drugmaker Eli Lilly remains interested in acquiring the French biotech.",
        "pubDate": "2026-01-12T11:14:00Z",
        "displayTime": "2026-01-12T11:14:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abivax-shares-surge-report-flags-111400639.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abivax-shares-surge-report-flags-111400639.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AAVXF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T10:03:00+00:00",
    "headline": "Abivax Surges on Report Ely Lilly is Preparing $17.5 Billion Bid",
    "summary": "Stock in the French company has been rising steadily since late July, and climbed as much as 30% in early trading Monday.",
    "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
      "content": {
        "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
        "contentType": "STORY",
        "title": "Abivax Surges on Report Ely Lilly is Preparing $17.5 Billion Bid",
        "description": "",
        "summary": "Stock in the French company has been rising steadily since late July, and climbed as much as 30% in early trading Monday.",
        "pubDate": "2026-01-12T10:03:00Z",
        "displayTime": "2026-01-12T10:03:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/fe057970-c6c6-386f-9920-c8e2f0dc2d38/abivax-surges-on-report-ely.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a0KQ6papa.xbdIRhdZYCpg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xfbO.4Knh6N3L0kymfSeuw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T13:05:00+00:00",
    "headline": "Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors",
    "summary": "Financing led by institutional investors, with participation from new investor Eli Lilly and CompanyInclusive of this investment, a total of $123 million in equity financing received from institutional and strategic investors to dateSeparately, Recludix announces collaboration with Lilly to utilize Lilly TuneLabâ„¢, a pioneering artificial intelligence and machine learning platform, to accelerate the development of Recludixâ€™s discovery pipeline SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Recludix",
    "url": "https://finance.yahoo.com/news/recludix-pharma-announces-equity-financing-130500214.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "23e1e315-0efb-36d7-8fb3-c9abdf159ab7",
      "content": {
        "id": "23e1e315-0efb-36d7-8fb3-c9abdf159ab7",
        "contentType": "STORY",
        "title": "Recludix Pharma Announces Equity Financing to Advance Clinical Development of Novel SH2 Domain Inhibitors",
        "description": "",
        "summary": "Financing led by institutional investors, with participation from new investor Eli Lilly and CompanyInclusive of this investment, a total of $123 million in equity financing received from institutional and strategic investors to dateSeparately, Recludix announces collaboration with Lilly to utilize Lilly TuneLabâ„¢, a pioneering artificial intelligence and machine learning platform, to accelerate the development of Recludixâ€™s discovery pipeline SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Recludix",
        "pubDate": "2026-01-12T13:05:00Z",
        "displayTime": "2026-01-12T13:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/3e3b7f225a2b77a1d1ea7d5025f01be2",
          "originalWidth": 842,
          "originalHeight": 325,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YBxgqYBDasfFycfbK8bENQ--~B/aD0zMjU7dz04NDI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3e3b7f225a2b77a1d1ea7d5025f01be2.cf.webp",
              "width": 842,
              "height": 325,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/knUi1j71UOIuwB0719OEbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/3e3b7f225a2b77a1d1ea7d5025f01be2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/recludix-pharma-announces-equity-financing-130500214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/recludix-pharma-announces-equity-financing-130500214.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T13:00:00+00:00",
    "headline": "Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors",
    "summary": "Commonwealth Fusion Systems (CFS), the largest and leading private fusion company, today announced that Stephane Bancel, the Chief Executive Officer of Moderna Inc. who led that company's successful development, production, scaling, and global adoption of the COVID-19 vaccine, has joined as an Independent Member of the Board of Directors.",
    "url": "https://finance.yahoo.com/news/commonwealth-fusion-systems-names-stephane-130000132.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "bded000d-3a58-3b3c-b11b-7046be448610",
      "content": {
        "id": "bded000d-3a58-3b3c-b11b-7046be448610",
        "contentType": "STORY",
        "title": "Commonwealth Fusion Systems Names Stephane Bancel to Board of Directors",
        "description": "",
        "summary": "Commonwealth Fusion Systems (CFS), the largest and leading private fusion company, today announced that Stephane Bancel, the Chief Executive Officer of Moderna Inc. who led that company's successful development, production, scaling, and global adoption of the COVID-19 vaccine, has joined as an Independent Member of the Board of Directors.",
        "pubDate": "2026-01-12T13:00:00Z",
        "displayTime": "2026-01-12T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/b97793f7da92c492e200f642baa5b1de",
          "originalWidth": 400,
          "originalHeight": 95,
          "caption": "Commonwealth Fusion Systems Logo (PRNewsfoto/Commonwealth Fusion Systems)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/owYIoMVoysNENfZHmnE60w--~B/aD05NTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/b97793f7da92c492e200f642baa5b1de.cf.webp",
              "width": 400,
              "height": 95,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6x9QQevw8RhDTEyNwha.bg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b97793f7da92c492e200f642baa5b1de.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/commonwealth-fusion-systems-names-stephane-130000132.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/commonwealth-fusion-systems-names-stephane-130000132.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "BMXMF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T10:03:00+00:00",
    "headline": "Abivax Surges on Report Eli Lilly is Preparing $17.5 Billion Bid",
    "summary": "Stock in the French company has been rising steadily since late July, and climbed as much as 30% in early trading Monday.",
    "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
      "content": {
        "id": "fe057970-c6c6-386f-9920-c8e2f0dc2d38",
        "contentType": "STORY",
        "title": "Abivax Surges on Report Eli Lilly is Preparing $17.5 Billion Bid",
        "description": "",
        "summary": "Stock in the French company has been rising steadily since late July, and climbed as much as 30% in early trading Monday.",
        "pubDate": "2026-01-12T10:03:00Z",
        "displayTime": "2026-01-12T10:03:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/fe057970-c6c6-386f-9920-c8e2f0dc2d38/abivax-surges-on-report-eli.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a0KQ6papa.xbdIRhdZYCpg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xfbO.4Knh6N3L0kymfSeuw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/def0e9da1b0363b6f5096ad97b72590c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/abivax-surges-on-report-ely-lily-is-preparing-17-5-billion-bid-119a6fc7?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T14:05:21+00:00",
    "headline": "Fed Chair Powell Faces US DOJ Criminal Probe, Equity Futures Waver Pre-Bell",
    "summary": "US equity futures were down ahead of Monday's opening bell after the US Department of Justice launch",
    "url": "https://finance.yahoo.com/news/fed-chair-powell-faces-us-140521462.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "c67cd4b7-4e89-3c3a-bbb4-420f9c3b4f29",
      "content": {
        "id": "c67cd4b7-4e89-3c3a-bbb4-420f9c3b4f29",
        "contentType": "STORY",
        "title": "Fed Chair Powell Faces US DOJ Criminal Probe, Equity Futures Waver Pre-Bell",
        "description": "",
        "summary": "US equity futures were down ahead of Monday's opening bell after the US Department of Justice launch",
        "pubDate": "2026-01-12T14:05:21Z",
        "displayTime": "2026-01-12T14:05:21Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fed-chair-powell-faces-us-140521462.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fed-chair-powell-faces-us-140521462.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T14:00:00+00:00",
    "headline": "CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program",
    "summary": "LOUISVILLE, Ky., January 12, 2026--CenterWell Pharmacy to dispense obesity management medications as part of new, employer-focused program.",
    "url": "https://finance.yahoo.com/news/centerwell-pharmacy-dispense-obesity-management-140000778.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "8191ee6c-7f90-37c6-ab86-37d4bc590bde",
      "content": {
        "id": "8191ee6c-7f90-37c6-ab86-37d4bc590bde",
        "contentType": "STORY",
        "title": "CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program",
        "description": "",
        "summary": "LOUISVILLE, Ky., January 12, 2026--CenterWell Pharmacy to dispense obesity management medications as part of new, employer-focused program.",
        "pubDate": "2026-01-12T14:00:00Z",
        "displayTime": "2026-01-12T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/a385ea1c73438a43509044f80083ad69",
          "originalWidth": 2334,
          "originalHeight": 952,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/avC7MLz9.maPskKvNkJP0w--~B/aD05NTI7dz0yMzM0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/a385ea1c73438a43509044f80083ad69.cf.webp",
              "width": 2334,
              "height": 952,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u8AbGBmbEm_2u7g6j3Q8eQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a385ea1c73438a43509044f80083ad69.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/centerwell-pharmacy-dispense-obesity-management-140000778.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/centerwell-pharmacy-dispense-obesity-management-140000778.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "HUM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T13:45:00+00:00",
    "headline": "HealthDyne Helps Advance Access to Obesity Treatment by Supporting New Carve-Out Benefit Options",
    "summary": "HealthDyne announced it will participate in alternative access solutions for employers seeking access to FDA-approved obesity management medicine from Eli Lilly and Company (Lilly). HealthDyne will become a dispensing pharmacy for select Lilly medicines collaborating with digital healthcare providers to offer integrated carve-out solutions that combine affordability, clinical oversight and patient engagement.",
    "url": "https://finance.yahoo.com/news/healthdyne-helps-advance-access-obesity-134500839.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "0c8bc856-2338-33ba-8c50-e73d247d8d92",
      "content": {
        "id": "0c8bc856-2338-33ba-8c50-e73d247d8d92",
        "contentType": "STORY",
        "title": "HealthDyne Helps Advance Access to Obesity Treatment by Supporting New Carve-Out Benefit Options",
        "description": "",
        "summary": "HealthDyne announced it will participate in alternative access solutions for employers seeking access to FDA-approved obesity management medicine from Eli Lilly and Company (Lilly). HealthDyne will become a dispensing pharmacy for select Lilly medicines collaborating with digital healthcare providers to offer integrated carve-out solutions that combine affordability, clinical oversight and patient engagement.",
        "pubDate": "2026-01-12T13:45:00Z",
        "displayTime": "2026-01-12T13:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/ba72895b5fbeb779f550f8db39c2a7ba",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C7AiYx_nEJqBWJouorPP4g--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/ba72895b5fbeb779f550f8db39c2a7ba.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/riIBFlyAU7GxIafZY3HwgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/ba72895b5fbeb779f550f8db39c2a7ba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/healthdyne-helps-advance-access-obesity-134500839.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/healthdyne-helps-advance-access-obesity-134500839.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T15:00:00+00:00",
    "headline": "NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery",
    "summary": "NVIDIA BioNeMo NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery. News Summary: Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific discovery.Chai Discovery, Basecamp Research, Boltz and ecosystem leaders connect NVIDIA BioNeM",
    "url": "https://finance.yahoo.com/news/nvidia-bionemo-platform-adopted-life-150000483.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "afd72fd4-a52d-34df-8d14-160c46a88f50",
      "content": {
        "id": "afd72fd4-a52d-34df-8d14-160c46a88f50",
        "contentType": "STORY",
        "title": "NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery",
        "description": "",
        "summary": "NVIDIA BioNeMo NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery. News Summary: Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to build autonomous lab infrastructure for scalable scientific discovery.Chai Discovery, Basecamp Research, Boltz and ecosystem leaders connect NVIDIA BioNeM",
        "pubDate": "2026-01-12T15:00:00Z",
        "displayTime": "2026-01-12T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/231be7c6bbceb2b840a567565df830cf",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "NVIDIA today announced a major expansion of NVIDIA BioNeMo, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zbodgO5oxmH4Rv9PmUo.1Q--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/231be7c6bbceb2b840a567565df830cf.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_H_a.Z2heqxgOgcoztCbBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/231be7c6bbceb2b840a567565df830cf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nvidia-bionemo-platform-adopted-life-150000483.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nvidia-bionemo-platform-adopted-life-150000483.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "TMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T15:00:00+00:00",
    "headline": "NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI",
    "summary": "Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research NVIDIA and Lilly NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry. News Summary: NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery.The co-innovation l",
    "url": "https://finance.yahoo.com/news/nvidia-lilly-announce-co-innovation-150000104.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "b04464c1-3627-34b5-8ca4-6a1905b9090f",
      "content": {
        "id": "b04464c1-3627-34b5-8ca4-6a1905b9090f",
        "contentType": "STORY",
        "title": "NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI",
        "description": "",
        "summary": "Companies to Jointly Invest up to $1 Billion Over Five Years in Infrastructure and Research NVIDIA and Lilly NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry. News Summary: NVIDIA and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery.The co-innovation l",
        "pubDate": "2026-01-12T15:00:00Z",
        "displayTime": "2026-01-12T15:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/5e0080b8f9c1e3d09261ca3f4d7e5650",
          "originalWidth": 1920,
          "originalHeight": 1080,
          "caption": "NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TU4JlcNigdjT3_WaNC_Qnw--~B/aD0xMDgwO3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/5e0080b8f9c1e3d09261ca3f4d7e5650.cf.webp",
              "width": 1920,
              "height": 1080,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WZ3OAq2pfw.zFwF0GnT.qg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5e0080b8f9c1e3d09261ca3f4d7e5650.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nvidia-lilly-announce-co-innovation-150000104.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nvidia-lilly-announce-co-innovation-150000104.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T14:51:00+00:00",
    "headline": "This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest.",
    "summary": "Eli Lillyâ€™s  presence in France has spanned more than six decades, but rumors of an acquisition suggest the pharmaceutical giant could be looking to expand its footprint in the country.  French outlet La Lettre reported Monday that biotechnology company  Abivax  had become the subject of takeover interest by Lilly, which was prepared to offer 15 billion euros, or roughly $17.5 billion, to acquire it.  Eli Lilly  has yet to support a formal bid to Abivaxâ€™s board as it awaits clarity from French regulators on whether a bid would be subject to Franceâ€™s foreign investment rules, the outlet reported.",
    "url": "https://www.barrons.com/articles/abivax-stock-price-eli-lilly-deal-d4360e1e?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "a7abd53d-3ed6-3631-bfad-37196920933b",
      "content": {
        "id": "a7abd53d-3ed6-3631-bfad-37196920933b",
        "contentType": "STORY",
        "title": "This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest.",
        "description": "",
        "summary": "Eli Lillyâ€™s  presence in France has spanned more than six decades, but rumors of an acquisition suggest the pharmaceutical giant could be looking to expand its footprint in the country.  French outlet La Lettre reported Monday that biotechnology company  Abivax  had become the subject of takeover interest by Lilly, which was prepared to offer 15 billion euros, or roughly $17.5 billion, to acquire it.  Eli Lilly  has yet to support a formal bid to Abivaxâ€™s board as it awaits clarity from French regulators on whether a bid would be subject to Franceâ€™s foreign investment rules, the outlet reported.",
        "pubDate": "2026-01-12T14:51:00Z",
        "displayTime": "2026-01-12T14:51:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a7abd53d-3ed6-3631-bfad-37196920933b/this-french-biotech-stock.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/aa4b51bd729b6cb38a349a611d8136aa",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dhNlx7ecuK6QafFFfsVpsw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/aa4b51bd729b6cb38a349a611d8136aa.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/aUECCd97R2XwtfU7jy0ObQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/aa4b51bd729b6cb38a349a611d8136aa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/abivax-stock-price-eli-lilly-deal-d4360e1e?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AAVXF"
            },
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "FNLPF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T13:57:00+00:00",
    "headline": "RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models",
    "summary": "Revvity teams up with Eli Lilly to bring TuneLab AI models to Signals Xynthetica, aiming to unlock secure, federated drug discovery at scale.",
    "url": "https://finance.yahoo.com/news/rvty-eli-lilly-partner-expand-135700194.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "28d1979b-29b2-32f1-af12-38a0e9077220",
      "content": {
        "id": "28d1979b-29b2-32f1-af12-38a0e9077220",
        "contentType": "STORY",
        "title": "RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models",
        "description": "",
        "summary": "Revvity teams up with Eli Lilly to bring TuneLab AI models to Signals Xynthetica, aiming to unlock secure, federated drug discovery at scale.",
        "pubDate": "2026-01-12T13:57:00Z",
        "displayTime": "2026-01-12T13:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574",
          "originalWidth": 620,
          "originalHeight": 343,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N5xEJDQ9Yr4pXNEJ_c.8WA--~B/aD0zNDM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574.cf.webp",
              "width": 620,
              "height": 343,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j8jgIs0er2qzWmssl7aBuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/rvty-eli-lilly-partner-expand-135700194.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/rvty-eli-lilly-partner-expand-135700194.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RVTY"
            },
            {
              "symbol": "CRL"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T16:17:34+00:00",
    "headline": "JPM26: Eli Lilly reportedly eyes â‚¬15bn takeover of Abivax",
    "summary": "Abivaxâ€™s lead asset is obefazimod, an anti-inflammatory drug that has produced positive Phase III results.",
    "url": "https://www.pharmaceutical-technology.com/news/jpm26-eli-lilly-reportedly-eyes-e15bn-takeover-of-abivax/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "15ea28e6-b5de-3a26-895b-0e67fe1b2565",
      "content": {
        "id": "15ea28e6-b5de-3a26-895b-0e67fe1b2565",
        "contentType": "STORY",
        "title": "JPM26: Eli Lilly reportedly eyes â‚¬15bn takeover of Abivax",
        "description": "",
        "summary": "Abivaxâ€™s lead asset is obefazimod, an anti-inflammatory drug that has produced positive Phase III results.",
        "pubDate": "2026-01-12T16:17:34Z",
        "displayTime": "2026-01-12T16:17:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/4ec4aca828f81e62e94e7742026b1f18",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XAdWeoi2P6Dl_5Mp8rzNLg--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/4ec4aca828f81e62e94e7742026b1f18.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yP_alcZqHRAi6o7KKxJUoQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/4ec4aca828f81e62e94e7742026b1f18.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/jpm26-eli-lilly-reportedly-eyes-e15bn-takeover-of-abivax/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-eli-lilly-reportedly-eyes-161734787.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABVX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T16:00:00+00:00",
    "headline": "Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline",
    "summary": "REDWOOD CITY, Calif., January 12, 2026--Juvena Therapeutics, a clinical-stage biotechnology company whose AI-enabled regenerative biologics are designed to restore tissue function, today announced its $33.5 million Series B. The round was led by Bison Ventures with participation from Eli Lilly and Company, Jefferson Life Sciences, and existing institutional backers including Mubadala Capital and Manta Ray.",
    "url": "https://finance.yahoo.com/news/juvena-therapeutics-raises-33-5m-160000042.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "07e42e2e-0c72-30ad-9c12-f7ef274df8f0",
      "content": {
        "id": "07e42e2e-0c72-30ad-9c12-f7ef274df8f0",
        "contentType": "STORY",
        "title": "Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipeline",
        "description": "",
        "summary": "REDWOOD CITY, Calif., January 12, 2026--Juvena Therapeutics, a clinical-stage biotechnology company whose AI-enabled regenerative biologics are designed to restore tissue function, today announced its $33.5 million Series B. The round was led by Bison Ventures with participation from Eli Lilly and Company, Jefferson Life Sciences, and existing institutional backers including Mubadala Capital and Manta Ray.",
        "pubDate": "2026-01-12T16:00:00Z",
        "displayTime": "2026-01-12T16:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/6b1601d19f21ece17f11aaed7da924ad",
          "originalWidth": 480,
          "originalHeight": 284,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/e9EpsPh_XHUyI_Oeva2ycg--~B/aD0yODQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6b1601d19f21ece17f11aaed7da924ad.cf.webp",
              "width": 480,
              "height": 284,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YGItkTCMIOmy.DpMsu33Vg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6b1601d19f21ece17f11aaed7da924ad.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/juvena-therapeutics-raises-33-5m-160000042.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/juvena-therapeutics-raises-33-5m-160000042.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T15:27:43+00:00",
    "headline": "Nvidia Partners With Eli Lilly on AI Drug Laboratory",
    "summary": "Nvidia plans to invest $1 billion over five years in a new laboratory with&nbsp;Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.&nbsp;Jessica Nix has more on \"Bloomberg Open Interest.\"",
    "url": "https://finance.yahoo.com/video/nvidia-partners-eli-lilly-ai-152743875.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "03e99bf2-f48c-3c42-8bea-4e8ff4f9db1e",
      "content": {
        "id": "03e99bf2-f48c-3c42-8bea-4e8ff4f9db1e",
        "contentType": "VIDEO",
        "title": "Nvidia Partners With Eli Lilly on AI Drug Laboratory",
        "description": "Nvidia plans to invest $1 billion over five years in a new laboratory withÂ Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.Â Jessica Nix has more on \"Bloomberg Open Interest.\"",
        "summary": "Nvidia plans to invest $1 billion over five years in a new laboratory with&nbsp;Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry.&nbsp;Jessica Nix has more on \"Bloomberg Open Interest.\"",
        "pubDate": "2026-01-12T15:27:43Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_markets_video_2/2418f3bccb232dd3cd0d3d9ccd1a2539",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AmdAIghX5MZA_AEh9xVGjA--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_video_2/2418f3bccb232dd3cd0d3d9ccd1a2539.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wy0RIX3HA.sZYZwBN9CrRg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_markets_video_2/2418f3bccb232dd3cd0d3d9ccd1a2539.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/nvidia-partners-eli-lilly-ai-152743875.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/nvidia-partners-eli-lilly-ai-152743875.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T14:45:04+00:00",
    "headline": "Here's Why Eli Lilly (LLY) is a Strong Growth Stock",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finance.yahoo.com/news/heres-why-eli-lilly-lly-144504168.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "52d67e4d-575b-38d4-b2d6-99c01f258a6d",
      "content": {
        "id": "52d67e4d-575b-38d4-b2d6-99c01f258a6d",
        "contentType": "STORY",
        "title": "Here's Why Eli Lilly (LLY) is a Strong Growth Stock",
        "description": "",
        "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
        "pubDate": "2026-01-12T14:45:04Z",
        "displayTime": "2026-01-12T14:45:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9",
          "originalWidth": 900,
          "originalHeight": 601,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VQTahvfxY5Qw8Ld_ibk8SA--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9.cf.webp",
              "width": 900,
              "height": 601,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uIfVIw8I.vo0_xUfE1XIrw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/48ad4265c55e3ba7a1fb9148d6e717d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-eli-lilly-lly-144504168.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-eli-lilly-lly-144504168.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T16:34:46+00:00",
    "headline": "Nvidia, Eli Lilly announce $1 billion investment in AI drug discovery lab",
    "summary": "Nvidia and Eli Lilly are set to launch an AI lab in San Francisco.",
    "url": "https://finance.yahoo.com/news/nvidia-eli-lilly-announce-1-billion-investment-in-ai-drug-discovery-lab-163446796.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "285a6899-e421-41b6-851c-98cecf3a592b",
      "content": {
        "id": "285a6899-e421-41b6-851c-98cecf3a592b",
        "contentType": "STORY",
        "title": "Nvidia, Eli Lilly announce $1 billion investment in AI drug discovery lab",
        "description": "",
        "summary": "Nvidia and Eli Lilly are set to launch an AI lab in San Francisco.",
        "pubDate": "2026-01-12T16:34:46Z",
        "displayTime": "2026-01-12T16:34:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/3438c520-ec06-11f0-bddf-75be531c7130",
          "originalWidth": 4455,
          "originalHeight": 2970,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Qhhkkb9V70QNdbSgRjXVaA--~B/aD0yOTcwO3c9NDQ1NTthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/3438c520-ec06-11f0-bddf-75be531c7130.cf.webp",
              "width": 4455,
              "height": 2970,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fgnTa_Xi3A7jiIgM.heFgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/3438c520-ec06-11f0-bddf-75be531c7130.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nvidia-eli-lilly-announce-1-billion-investment-in-ai-drug-discovery-lab-163446796.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nvidia-eli-lilly-announce-1-billion-investment-in-ai-drug-discovery-lab-163446796.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "ILMN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T16:38:00+00:00",
    "headline": "â€˜Biotech Super Bowlâ€™ Lands With a Thud. Stocks Slide on Lack of Deal News.",
    "summary": "Monday is the first day of  J.P. Morganâ€™s  annual healthcare investor conference, which draws thousands of investors, analysts, and executives to San Francisco each year.  There is ample precedent: Last year,  Johnson & Johnson  announced a $14.6 billion deal to acquire Intra-Cellular Therapeutics on the first day of the gathering.  The Wall Street Journal reported last week that Merck was in talks to buy the biotech Revolution Medicines for roughly $30 billion, but as of late morning, no such agreement had been announced.",
    "url": "https://www.barrons.com/articles/biotech-stocks-chase-conference-b9cab762?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "b75019f7-5087-30b3-a925-6f9de1cc8a35",
      "content": {
        "id": "b75019f7-5087-30b3-a925-6f9de1cc8a35",
        "contentType": "STORY",
        "title": "â€˜Biotech Super Bowlâ€™ Lands With a Thud. Stocks Slide on Lack of Deal News.",
        "description": "",
        "summary": "Monday is the first day of  J.P. Morganâ€™s  annual healthcare investor conference, which draws thousands of investors, analysts, and executives to San Francisco each year.  There is ample precedent: Last year,  Johnson & Johnson  announced a $14.6 billion deal to acquire Intra-Cellular Therapeutics on the first day of the gathering.  The Wall Street Journal reported last week that Merck was in talks to buy the biotech Revolution Medicines for roughly $30 billion, but as of late morning, no such agreement had been announced.",
        "pubDate": "2026-01-12T16:38:00Z",
        "displayTime": "2026-01-12T16:38:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b75019f7-5087-30b3-a925-6f9de1cc8a35/%E2%80%98biotech-super-bowl%E2%80%99-lands.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/8ebdb690c83f7dcd8efc0f89134f191d",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BHJPDjWZKaPfXg5a3nUTWQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/8ebdb690c83f7dcd8efc0f89134f191d.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qa7w9DeR_tRxUp5wVzRzPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/8ebdb690c83f7dcd8efc0f89134f191d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/biotech-stocks-chase-conference-b9cab762?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "XBI"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T15:50:00+00:00",
    "headline": "Nvidia Stock Slips. The Chip Maker Is Launching an AI Lab with Eli Lilly.",
    "summary": "Nvidia  stock was languishing Monday despite news of a partnership with pharmaceutical company  Eli Lilly  The chip companyâ€™s investors remain focused progress on sales in China and the health of the wider artificial-intelligence sector.  The stock is down 1.8% over the past month, as a flurry of robotics and autonomous-driving related announcements at the CES trade show, formerly known as the Consumer Electronics Show, failed to provide a boost.  Nvidia said Monday that it was joining with  Eli Lilly  to fund an AI lab with an investment of up to $1 billion over five years to build models for biology and chemistry.",
    "url": "https://www.barrons.com/articles/nvidia-stock-price-ai-chips-china-8bfa9df6?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "d16db3c2-f6d3-31cc-82be-983f3100a40a",
      "content": {
        "id": "d16db3c2-f6d3-31cc-82be-983f3100a40a",
        "contentType": "STORY",
        "title": "Nvidia Stock Slips. The Chip Maker Is Launching an AI Lab with Eli Lilly.",
        "description": "",
        "summary": "Nvidia  stock was languishing Monday despite news of a partnership with pharmaceutical company  Eli Lilly  The chip companyâ€™s investors remain focused progress on sales in China and the health of the wider artificial-intelligence sector.  The stock is down 1.8% over the past month, as a flurry of robotics and autonomous-driving related announcements at the CES trade show, formerly known as the Consumer Electronics Show, failed to provide a boost.  Nvidia said Monday that it was joining with  Eli Lilly  to fund an AI lab with an investment of up to $1 billion over five years to build models for biology and chemistry.",
        "pubDate": "2026-01-12T15:50:00Z",
        "displayTime": "2026-01-12T15:50:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d16db3c2-f6d3-31cc-82be-983f3100a40a/nvidia-stock-slips-the-chip.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/be00bb99d7efcf60ce12acbbe3b3af0e",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oZcifyGj6h9MOtnoJ8CmvA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/be00bb99d7efcf60ce12acbbe3b3af0e.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TvY4CiQosc3vLfDRsAhy4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/be00bb99d7efcf60ce12acbbe3b3af0e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/nvidia-stock-price-ai-chips-china-8bfa9df6?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "TSM"
            },
            {
              "symbol": "TSMWF"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T18:14:54+00:00",
    "headline": "TSMC rises on reported USâ€“Taiwan deal, Nvidia & Eli Lilly team up",
    "summary": "Yahoo Finance Senior Reporter Brooke DiPalma tracks Monday's top moving stocks and biggest market stories in this Market Minute. Taiwan Semiconductor Manufacturing Company (TSM) stock is moving higher on a New York Times report that the Trump administration is close to reaching a trade agreement with Taiwan. Nvidia (NVDA) and Eli Lilly (LLY) are partnering on drug discovery, jointly investing $1 billion to create a lab in San Francisco. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finance.yahoo.com/video/tsmc-rises-reported-us-taiwan-181454197.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "e86ee694-37f3-3935-846c-7a2723f913bd",
      "content": {
        "id": "e86ee694-37f3-3935-846c-7a2723f913bd",
        "contentType": "VIDEO",
        "title": "TSMC rises on reported USâ€“Taiwan deal, Nvidia & Eli Lilly team up",
        "description": "<p>Yahoo Finance Senior Reporter <a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/author/brooke-dipalma/?fr=sycsrp_catchall\">Brooke DiPalma</a> tracks Monday's <a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/markets/stocks/trending/\">top moving stocks</a> and biggest market stories in this<a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-minute/\"> Market Minute</a>.</p>\n<p>Taiwan Semiconductor Manufacturing Company (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/TSM\">TSM</a>) stock is moving higher on a <a data-i13n=\"cpos:5;pos:1\" href=\"https://www.nytimes.com/2026/01/12/business/economy/trump-taiwan-deal.html\">New York Times report</a> that the Trump administration is close to reaching a trade agreement with Taiwan.</p>\n<p>Nvidia (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/NVDA\">NVDA</a>) and Eli Lilly (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/LLY\">LLY</a>) are partnering on drug discovery, jointly investing $1 billion to create a lab in San Francisco.</p>\n<p>Stay up to date on the latest market action, minute-by-minute, with <a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-minute/\">Yahoo Finance's Market Minute.</a></p>",
        "summary": "Yahoo Finance Senior Reporter Brooke DiPalma tracks Monday's top moving stocks and biggest market stories in this Market Minute. Taiwan Semiconductor Manufacturing Company (TSM) stock is moving higher on a New York Times report that the Trump administration is close to reaching a trade agreement with Taiwan. Nvidia (NVDA) and Eli Lilly (LLY) are partnering on drug discovery, jointly investing $1 billion to create a lab in San Francisco. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
        "pubDate": "2026-01-12T18:14:54Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/0a921ac0-efe2-11f0-b677-3a933a27f6c9",
          "originalWidth": 5000,
          "originalHeight": 2810,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zA5ZCYfNWyvnW_YeZGmJmg--~B/aD0yODEwO3c9NTAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/0a921ac0-efe2-11f0-b677-3a933a27f6c9.cf.webp",
              "width": 5000,
              "height": 2810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mCg11S5eiuMox.i.hy4srw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/0a921ac0-efe2-11f0-b677-3a933a27f6c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/tsmc-rises-reported-us-taiwan-181454197.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/tsmc-rises-reported-us-taiwan-181454197.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TSM"
            },
            {
              "symbol": "TSMWF"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T18:25:58+00:00",
    "headline": "JPM26: Eli Lilly and NVIDIA deepen ties with $1bn AI partnership",
    "summary": "A new co-innovation lab in the San Francisco Bay area will see Lilly and NVIDIA scientists work alongside each other to fuel drug discovery improvements.",
    "url": "https://www.medicaldevice-network.com/news/jpm26-eli-lilly-and-nvidia-deepen-ties-with-1bn-ai-partnership/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "921feabc-38c0-399e-bb69-6d39f6e8532f",
      "content": {
        "id": "921feabc-38c0-399e-bb69-6d39f6e8532f",
        "contentType": "STORY",
        "title": "JPM26: Eli Lilly and NVIDIA deepen ties with $1bn AI partnership",
        "description": "",
        "summary": "A new co-innovation lab in the San Francisco Bay area will see Lilly and NVIDIA scientists work alongside each other to fuel drug discovery improvements.",
        "pubDate": "2026-01-12T18:25:58Z",
        "displayTime": "2026-01-12T18:25:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/9b007e939e8c0aae244f280f85b33240",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH1qUqnpqcWdmyi46nP_eg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/9b007e939e8c0aae244f280f85b33240.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ud9LwNSlm1QT4XensyypAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/9b007e939e8c0aae244f280f85b33240.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/news/jpm26-eli-lilly-and-nvidia-deepen-ties-with-1bn-ai-partnership/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-eli-lilly-nvidia-deepen-182558034.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T18:08:18+00:00",
    "headline": "Tempus AI's Pharma Momentum Accelerates",
    "summary": "Contract value passes $1.1 billion milestone",
    "url": "https://finance.yahoo.com/news/tempus-ais-pharma-momentum-accelerates-180818076.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "85ac4bd2-efe2-3f01-adfd-cada976dde73",
      "content": {
        "id": "85ac4bd2-efe2-3f01-adfd-cada976dde73",
        "contentType": "STORY",
        "title": "Tempus AI's Pharma Momentum Accelerates",
        "description": "",
        "summary": "Contract value passes $1.1 billion milestone",
        "pubDate": "2026-01-12T18:08:18Z",
        "displayTime": "2026-01-12T18:08:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/f59527b0d156b3bd2c9001300b62b795",
          "originalWidth": 3427,
          "originalHeight": 2263,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iP6UfZGBZGVTwO_16QJRfQ--~B/aD0yMjYzO3c9MzQyNzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/f59527b0d156b3bd2c9001300b62b795.cf.webp",
              "width": 3427,
              "height": 2263,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YLvDHMnsi9kcSTsCJp81Ew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/f59527b0d156b3bd2c9001300b62b795.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tempus-ais-pharma-momentum-accelerates-180818076.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tempus-ais-pharma-momentum-accelerates-180818076.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TEM"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T18:05:56+00:00",
    "headline": "Nvidia Partners With Biotech Firms On AI Drug Discovery",
    "summary": "Nvidia announced AI partnerships with two biotech firms to transform the way lifesaving drugs are discovered and manufactured.",
    "url": "https://www.investors.com/news/technology/nvidia-stock-ai-leader-partners-biotech-firms/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "5a97e0da-fb16-3509-bb94-818e1a54eebd",
      "content": {
        "id": "5a97e0da-fb16-3509-bb94-818e1a54eebd",
        "contentType": "STORY",
        "title": "Nvidia Partners With Biotech Firms On AI Drug Discovery",
        "description": "",
        "summary": "Nvidia announced AI partnerships with two biotech firms to transform the way lifesaving drugs are discovered and manufactured.",
        "pubDate": "2026-01-12T18:05:56Z",
        "displayTime": "2026-01-12T18:05:56Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/5a97e0da-fb16-3509-bb94-818e1a54eebd/nvidia-partners-with-biotech.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/9e49eeec4e1d906e892574096ad4afcb",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SGimJnc8fjUKfIwdI0FFbA--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/9e49eeec4e1d906e892574096ad4afcb.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Cn0dRU0IqcrUJVqXBVx5tw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/9e49eeec4e1d906e892574096ad4afcb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/nvidia-stock-ai-leader-partners-biotech-firms/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "TMO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T18:05:01+00:00",
    "headline": "BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio",
    "summary": "BioAge shares catapulted Monday on promising results for the company's cardiovascular diseases treatment, which could eventually rival Eli Lilly.",
    "url": "https://www.investors.com/news/technology/bioage-labs-bioage-stock-eli-lilly-ventyx-biosciences-nlrp3/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "439cbe17-e1aa-3b76-b84a-901b4de99f64",
      "content": {
        "id": "439cbe17-e1aa-3b76-b84a-901b4de99f64",
        "contentType": "STORY",
        "title": "BioAge Rockets As It Takes On Eli Lilly's Takeover Play, Ventyx Bio",
        "description": "",
        "summary": "BioAge shares catapulted Monday on promising results for the company's cardiovascular diseases treatment, which could eventually rival Eli Lilly.",
        "pubDate": "2026-01-12T18:05:01Z",
        "displayTime": "2026-01-12T18:05:01Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/439cbe17-e1aa-3b76-b84a-901b4de99f64/bioage-rockets-as-it-takes-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/c0fb77c27ea4e241879b0c3f450366fb",
          "originalWidth": 1000,
          "originalHeight": 565,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fRnc9LtrZO1SIIgSMayQvQ--~B/aD01NjU7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/c0fb77c27ea4e241879b0c3f450366fb.cf.webp",
              "width": 1000,
              "height": 565,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/adAb.KWvgqjVz8XXBhgdaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/c0fb77c27ea4e241879b0c3f450366fb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/bioage-labs-bioage-stock-eli-lilly-ventyx-biosciences-nlrp3/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIOA"
            },
            {
              "symbol": "VTYX"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T17:48:17+00:00",
    "headline": "Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharmaâ€™s Future",
    "summary": "One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive amounts of data far faster than humans, identifying potential drug candidates and predicting their effects. This could cut years off the traditional process, which often takes over a decade and costs billions. Eli Lilly ... Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharmaâ€™s Future",
    "url": "https://247wallst.com/investing/2026/01/12/eli-lilly-and-nvidia-make-1-billion-ai-bet-to-revolutionize-pharmas-future/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b8055f31-cf95-3b30-9f3b-4e51f46f93e4",
      "content": {
        "id": "b8055f31-cf95-3b30-9f3b-4e51f46f93e4",
        "contentType": "STORY",
        "title": "Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharmaâ€™s Future",
        "description": "",
        "summary": "One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive amounts of data far faster than humans, identifying potential drug candidates and predicting their effects. This could cut years off the traditional process, which often takes over a decade and costs billions. Eli Lilly ... Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharmaâ€™s Future",
        "pubDate": "2026-01-12T17:48:17Z",
        "displayTime": "2026-01-12T17:48:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/4b91bbbbcd94f5a5956b3585227eb6ca",
          "originalWidth": 1366,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/c8cnWmzkj.0C.Q.ThUrxnA--~B/aD03Njg7dz0xMzY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/4b91bbbbcd94f5a5956b3585227eb6ca.cf.webp",
              "width": 1366,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HCv1HmpclwEhtmR7PEvN3Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/4b91bbbbcd94f5a5956b3585227eb6ca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2026/01/12/eli-lilly-and-nvidia-make-1-billion-ai-bet-to-revolutionize-pharmas-future/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-nvidia-1-billion-174817413.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T17:29:00+00:00",
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Find insight on U.S. pharmaceutical companiesâ€™ cash positions, the Thai health-care sector and more in the latest Market Talks covering the health care sector.",
    "url": "https://www.wsj.com/business/health-care-roundup-market-talk-ba4bb526?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "435e338d-d14f-3580-954c-a610acc98c0f",
      "content": {
        "id": "435e338d-d14f-3580-954c-a610acc98c0f",
        "contentType": "STORY",
        "title": "Health Care Roundup: Market Talk",
        "description": "",
        "summary": "Find insight on U.S. pharmaceutical companiesâ€™ cash positions, the Thai health-care sector and more in the latest Market Talks covering the health care sector.",
        "pubDate": "2026-01-12T17:29:00Z",
        "displayTime": "2026-01-12T17:29:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/435e338d-d14f-3580-954c-a610acc98c0f/health-care-roundup-market.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/f2bec8dc98b10078f647d871658f461a",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WrhZrzCfqtmt.BmE13YeQA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/f2bec8dc98b10078f647d871658f461a.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OE1vcNqqSRZ1WIBYKKRlWQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/f2bec8dc98b10078f647d871658f461a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/business/health-care-roundup-market-talk-ba4bb526?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T19:57:00+00:00",
    "headline": "Adimab Reports Strong Partnering Year for 2025",
    "summary": "Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, today announced that it entered into partnership agreements with 23 companies in 2025. In addition, Adimab achieved 50 technical and development milestones across numerous collaborations.",
    "url": "https://finance.yahoo.com/news/adimab-reports-strong-partnering-2025-195700674.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "c81f17fa-fa29-33d4-a860-23867c74012e",
      "content": {
        "id": "c81f17fa-fa29-33d4-a860-23867c74012e",
        "contentType": "STORY",
        "title": "Adimab Reports Strong Partnering Year for 2025",
        "description": "",
        "summary": "Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, today announced that it entered into partnership agreements with 23 companies in 2025. In addition, Adimab achieved 50 technical and development milestones across numerous collaborations.",
        "pubDate": "2026-01-12T19:57:00Z",
        "displayTime": "2026-01-12T19:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/c0c3400c1b3d3f330f078e841f4163b5",
          "originalWidth": 400,
          "originalHeight": 120,
          "caption": "Adimab Logo CMYK",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mLu1GrjrbNUxIusxS1KLBg--~B/aD0xMjA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c0c3400c1b3d3f330f078e841f4163b5.cf.webp",
              "width": 400,
              "height": 120,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_GtZPoKfQ4PIVUkIEodNRw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/c0c3400c1b3d3f330f078e841f4163b5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/adimab-reports-strong-partnering-2025-195700674.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/adimab-reports-strong-partnering-2025-195700674.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ALNY"
            },
            {
              "symbol": "CGEM"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T22:45:00+00:00",
    "headline": "3 retail trends to watch in 2026, according to NRF 2026",
    "summary": "The National Retail Federation (NRF) is hosting its Retail's Big Show conference in New York City this week. Attending the event, Yahoo Finance Senior Reporter Brooke DiPalma sat down with KPMG US consumer & retail sector leader Duleep Rodrigo and PwC partner and US consumer markets industry leader Alison Furman to hear how retailers will be employing AI applications and how companies are expected to adjust to the adoption of GLP-1 weight-loss drugs and more active lifestyles by consumers. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Asking for a Trend.",
    "url": "https://finance.yahoo.com/video/3-retail-trends-watch-2026-224500459.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "064588e9-3daa-3043-aa6e-7e0e6776c6cf",
      "content": {
        "id": "064588e9-3daa-3043-aa6e-7e0e6776c6cf",
        "contentType": "VIDEO",
        "title": "3 retail trends to watch in 2026, according to NRF 2026",
        "description": "<p>The National Retail Federation (NRF) is hosting its Retail's Big Show conference in New York City this week.</p>\n<p>Attending the event, Yahoo Finance Senior Reporter <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/brooke-dipalma/\">Brooke DiPalma</a> sat down with KPMG US consumer & retail sector leader Duleep Rodrigo and PwC partner and US consumer markets industry leader Alison Furman to hear how retailers will be employing AI applications and how companies are expected to adjust to the adoption of GLP-1 weight-loss drugs and more active lifestyles by consumers.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out moreÂ <a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/videos/series/asking-for-a-trend/\">Asking for a Trend</a>.</p>",
        "summary": "The National Retail Federation (NRF) is hosting its Retail's Big Show conference in New York City this week. Attending the event, Yahoo Finance Senior Reporter Brooke DiPalma sat down with KPMG US consumer & retail sector leader Duleep Rodrigo and PwC partner and US consumer markets industry leader Alison Furman to hear how retailers will be employing AI applications and how companies are expected to adjust to the adoption of GLP-1 weight-loss drugs and more active lifestyles by consumers. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Asking for a Trend.",
        "pubDate": "2026-01-12T22:45:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/8c48f660-f005-11f0-aeb7-1fd78e6dbefe",
          "originalWidth": 4250,
          "originalHeight": 2390,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tMnqNZixVpW010P7QO1SHw--~B/aD0yMzkwO3c9NDI1MDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/8c48f660-f005-11f0-aeb7-1fd78e6dbefe.cf.webp",
              "width": 4250,
              "height": 2390,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OcryTWcyChhx_H5HhvKXog--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/8c48f660-f005-11f0-aeb7-1fd78e6dbefe.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/3-retail-trends-watch-2026-224500459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/3-retail-trends-watch-2026-224500459.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "XLP"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "XLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T21:29:00+00:00",
    "headline": "Nvidia Stock Closes Flat. The Chip Maker Is Launching an AI Lab with Eli Lilly.",
    "summary": "Nvidia  stock was languishing Monday despite news of a partnership with pharmaceutical company  Eli Lilly  The chip companyâ€™s investors remain focused progress on sales in China and the health of the wider artificial-intelligence sector.  The stock is down 1.8% over the past month, as a flurry of robotics and autonomous-driving related announcements at the CES trade show, formerly known as the Consumer Electronics Show, failed to provide a boost.  Nvidia said Monday that it was joining with  Eli Lilly  to fund an AI lab with an investment of up to $1 billion over five years to build models for biology and chemistry.",
    "url": "https://www.barrons.com/articles/nvidia-stock-price-ai-chips-china-8bfa9df6?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "d16db3c2-f6d3-31cc-82be-983f3100a40a",
      "content": {
        "id": "d16db3c2-f6d3-31cc-82be-983f3100a40a",
        "contentType": "STORY",
        "title": "Nvidia Stock Closes Flat. The Chip Maker Is Launching an AI Lab with Eli Lilly.",
        "description": "",
        "summary": "Nvidia  stock was languishing Monday despite news of a partnership with pharmaceutical company  Eli Lilly  The chip companyâ€™s investors remain focused progress on sales in China and the health of the wider artificial-intelligence sector.  The stock is down 1.8% over the past month, as a flurry of robotics and autonomous-driving related announcements at the CES trade show, formerly known as the Consumer Electronics Show, failed to provide a boost.  Nvidia said Monday that it was joining with  Eli Lilly  to fund an AI lab with an investment of up to $1 billion over five years to build models for biology and chemistry.",
        "pubDate": "2026-01-12T21:29:00Z",
        "displayTime": "2026-01-12T21:29:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d16db3c2-f6d3-31cc-82be-983f3100a40a/nvidia-stock-closes-flat-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/be00bb99d7efcf60ce12acbbe3b3af0e",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oZcifyGj6h9MOtnoJ8CmvA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/be00bb99d7efcf60ce12acbbe3b3af0e.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TvY4CiQosc3vLfDRsAhy4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/be00bb99d7efcf60ce12acbbe3b3af0e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/nvidia-stock-price-ai-chips-china-8bfa9df6?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "TMO"
            },
            {
              "symbol": "TSM"
            },
            {
              "symbol": "TSMWF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T21:21:00+00:00",
    "headline": "Expect a Busy Year in Obesity Drugs as New Pills Hit the Market",
    "summary": "Pill versions of the successful GLP1 drugs from Novo Nordisk and Eli Lilly will likely be on the market in 2026â€™s first half.",
    "url": "https://www.barrons.com/articles/obesity-drugs-pills-fda-ce526357?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "0b802b93-015b-337a-a44d-e51651c9fd69",
      "content": {
        "id": "0b802b93-015b-337a-a44d-e51651c9fd69",
        "contentType": "STORY",
        "title": "Expect a Busy Year in Obesity Drugs as New Pills Hit the Market",
        "description": "",
        "summary": "Pill versions of the successful GLP1 drugs from Novo Nordisk and Eli Lilly will likely be on the market in 2026â€™s first half.",
        "pubDate": "2026-01-12T21:21:00Z",
        "displayTime": "2026-01-12T21:21:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/0b802b93-015b-337a-a44d-e51651c9fd69/expect-a-busy-year-in-obesity.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/dc1c6f9012998f61fbc4f365deabfe09",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C9yL9x59djC1XvjyvVAfNQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/dc1c6f9012998f61fbc4f365deabfe09.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oFcwB0B9.gWnduYSZOmDZw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/dc1c6f9012998f61fbc4f365deabfe09.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/obesity-drugs-pills-fda-ce526357?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "ZLDPY"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "ZLDPF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T21:16:00+00:00",
    "headline": "Top Stock Reports for Microsoft, Eli Lilly & Lam Research",
    "summary": "Microsoft beat software peers as Azure's 25% cloud share and OpenAI-led AI lift cash flow, despite competition, regulation and rising AI capex.",
    "url": "https://finance.yahoo.com/news/top-stock-reports-microsoft-eli-211600623.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "4f8def8e-514c-3e8e-a679-36c723d4d5eb",
      "content": {
        "id": "4f8def8e-514c-3e8e-a679-36c723d4d5eb",
        "contentType": "STORY",
        "title": "Top Stock Reports for Microsoft, Eli Lilly & Lam Research",
        "description": "",
        "summary": "Microsoft beat software peers as Azure's 25% cloud share and OpenAI-led AI lift cash flow, despite competition, regulation and rising AI capex.",
        "pubDate": "2026-01-12T21:16:00Z",
        "displayTime": "2026-01-12T21:16:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbbe67baee1ebeef5549e8ab4ae080ae",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3NHDdW2TmDY96XPUJrFt1w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbbe67baee1ebeef5549e8ab4ae080ae.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_LL9Tjg1TLDVS54tM1wEPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbbe67baee1ebeef5549e8ab4ae080ae.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-stock-reports-microsoft-eli-211600623.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-stock-reports-microsoft-eli-211600623.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "CAH"
            },
            {
              "symbol": "MMC"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "LRCX"
            },
            {
              "symbol": "AP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T17:18:00+00:00",
    "headline": "JPM26: US biotechâ€™s â€˜Sputnik moment,â€™ Pfizerâ€™s obesity ambitions and Bristol Myersâ€™ big year",
    "summary": "Four recent deals fueled more angst about Chinaâ€™s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to appease jittery investors.",
    "url": "https://www.biopharmadive.com/news/jpm26-china-biotech-pfizer-obesity-bristol-sarepta-elevidys-sales/809320/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "90d9effa-b4ba-3553-ad33-7f3641f07a91",
      "content": {
        "id": "90d9effa-b4ba-3553-ad33-7f3641f07a91",
        "contentType": "STORY",
        "title": "JPM26: US biotechâ€™s â€˜Sputnik moment,â€™ Pfizerâ€™s obesity ambitions and Bristol Myersâ€™ big year",
        "description": "",
        "summary": "Four recent deals fueled more angst about Chinaâ€™s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to appease jittery investors.",
        "pubDate": "2026-01-12T17:18:00Z",
        "displayTime": "2026-01-12T17:18:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/7bd263bcae7d0506fb80282303540fe7",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "BioPharma Dive, an Industry Dive publication",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/U3g5.ulK0vcCqcdyFlYvVw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/7bd263bcae7d0506fb80282303540fe7.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DH6ljKWVk5FO27mUzvHUcQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/7bd263bcae7d0506fb80282303540fe7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/jpm26-china-biotech-pfizer-obesity-bristol-sarepta-elevidys-sales/809320/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jpm26-us-biotech-sputnik-moment-171800003.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]